We are pleased to announce that MB Therapeutics has obtained a Deeptech label from the BPI (Public Investment Bank). This label is associated with a development project for a turnkey solution for the production of personalized medicines using pharmaceutical 3D printing technology.

What is the Deeptech label?

With the Generation Deeptech plan, Bpifrance aims to foster the emergence of startups in France and enable them to grow through dedicated support programs.